In the tamoxifen resistance module, we include ERα66 and ERα36, two variants of estrogen receptor (ESR1)—ERα66 is associated with tamoxifen-sensitive cell state, while elevated levels of ERα36 drive resistance to tamoxifen in breast cancer cells [42]. Here, ESR1 is linked to breast carcinoma.